REFERENCES
- Bussemer T., Bodmeier R. A review of pulsatile drug delivery. Am. Pharm. Rev. 2001; 4(4)18–24
- Bussemer T., Dashevsky A., Bodmeier R. A pulsatile drug delivery system based on rupturable coated hard gelatin capsules. J. Control. Rel. 2003; 93: 331–339
- Bussemer T., Otto L., Bodmeier R. Pulsatile-drug delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 2001; 18(5)433–458
- Efentakis M., Koligliati S., Vlachou M. Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release. Int. J. Pharm. 2006; 311: 147–156
- Fan T. Y., Wei S. L., Yan W. W., Chen D. B., Li J. An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross-linked polyvinylpyrrolidone in core tablets. J. Control. Rel. 2001; 77: 245–251
- Freichel O. L., Lippold B. C. A new oral erosion controlled drug delivery system with a late burst in the release profile. Eur. J. Pharm. Biopharm. 2000; 50: 345–351
- Karavas E., Georgarakis E., Bikiaris D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur. J. Pharm. Biopharm. 2006a; 64(1)115–126
- Karavas E., Georgarakis E., Bikiaris D. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int. J. Pharm. 2006b; 313(1-2)189–197
- Krögel I., Bodmeier R. Evaluation of an enzyme-containing capsular shaped pulsatile drug delivery system. Pharm. Res. 1999a; 16(9)1424–1429
- Krögel I., Bodmeier R. Floating or pulsatile drug delivery systems based on coating effervescent cores. Int. J. Pharm. 1999b; 187: 175–184
- Lemmer B. Chronopharmacokinetic: implications for drug treatment. J. Pharm. Pharmacol. 1999; 51: 887–890
- Li Y. H., Zhu J. B. Oral site-specific drug delivery system, World pharmacy-a branch of synthetic drug. Biochem. Drug Pharmac. 2002; 23(4)225–228
- Maggi L., Conte U., Giunchedi P., Colombo P. Press-coated tablets for the sequential pulsed administration of two different drugs. Int. J. Pharm. 1993; 99: 173–179
- Morita R., Honda R., Takahashi Y. Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS); I. Design of SCRS and its release controlling factor. J. Control. Rel. 2000; 63: 297–304
- Sangalli M. E., Maroni A., Zema L., Busetti C., Giordano F., Gazzaniga A. In-vitro and in-vivo evaluation of an oral system for time and/or site-specific drug delivery. J. Control. Rel. 2001; 73: 103–110
- Sinha V. R., Bhinge J. R., Kumria R., Kumar M. Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer. Drug Del. 2006; 13(3)221–225
- Sungthongjeen S., Puttipipatkhachorn S., Paeratakul O., Dashevsky A., Bodmeier R. Development of pulsatile release tablets with swelling and rupturable layers. J. Control. Rel. 2004; 95: 147–159
- Thombre A. G., Appel L. E., Chidlaw M. B., Daugherity P. D., Dumont F., Evans L. A. F., Sutton S. C. Osmotic drug delivery using swellable-core technology. J. Control. Rel. 2004; 94: 75–89
- Ueda S., Ibuki R., Kimura S., Murata S., Takahashi T., Tokunaga Y., Hata T. Development of a novel release system, time controlled explosion system (TES). III. Relation between lag time and membrane thickness. Chem. Pharm. Bull. 1994; 42(2)364–367
- Wan L. S., Lim L. Y. Drug release from heat-treated polyvinyl alcohol films. Drug Dev. Ind. Pharm. 1992; 18: 1895–1906